Epidemiology, aetiology and screening of bladder cancer
作者： Marcus G. K. Cumberbatch , , Aidan P. Noon
关键词:
摘要: Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease paramount to improving prevention increasing public awareness. Historically BC has been of industrialized regions most responsible carcinogens are tobacco smoke occupational chemical exposure. incidence mortality differ dramatically by region reflect differences in factor exposure, healthcare behaviour, population demographics. Screening studies have suggested survival benefit amongst screened non-symptomatic populations with known factors, but not become standard practice.
amegroups.com参考文章(43)
, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873
Kirsten L Greene, Anna Berry, Badrinath R Konety, Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer. Reviews in urology. ,vol. 8, pp. 190- ,(2006)
Aidan P. Noon, Matthew J. Resnick, Shahrokh F. Shariat, Alexandre R. Zlotta, Stephen A. Boorjian, Jakub Dobruch, Siamak Daneshmand, Margit Fisch, Yair Lotan, Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes European Urology. ,vol. 69, pp. 300- 310 ,(2016) , 10.1016/J.EURURO.2015.08.037
Francis Thomas, Derek J. Rosario, Naomi Rubin, John R. Goepel, Maysam F. Abbod, James W. F. Catto, The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm? Cancer. ,vol. 118, pp. 5525- 5534 ,(2012) , 10.1002/CNCR.27587
Richard M Turner, Chun S Kwok, Chen Chen‐Turner, Chinedu A Maduakor, Sonal Singh, Yoon K Loke, None, Thiazolidinediones and associated risk of Bladder Cancer: a Systematic Review and Meta-analysis British Journal of Clinical Pharmacology. ,vol. 78, pp. 258- 273 ,(2014) , 10.1111/BCP.12306
Jonine D. Figueroa, Stella Koutros, Joanne S. Colt, Manolis Kogevinas, Montserrat Garcia-Closas, Francisco X. Real, Melissa C. Friesen, Dalsu Baris, Patricia Stewart, Molly Schwenn, Alison Johnson, Margaret R. Karagas, Karla R. Armenti, Lee E. Moore, Alan Schned, Petra Lenz, Ludmila Prokunina-Olsson, A. Rouf Banday, Ashley Paquin, Kris Ylaya, Joon-Yong Chung, Stephen M. Hewitt, Michael L. Nickerson, Adonina Tardón, Consol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Núria Malats, Joseph F. Fraumeni, Stephen J. Chanock, Nilanjan Chatterjee, Nathaniel Rothman, Debra T. Silverman, Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms Journal of the National Cancer Institute. ,vol. 107, ,(2015) , 10.1093/JNCI/DJV223
James D. Lewis, Laurel A. Habel, Charles P. Quesenberry, Brian L. Strom, Tiffany Peng, Monique M. Hedderson, Samantha F. Ehrlich, Ronac Mamtani, Warren Bilker, David J. Vaughn, Lisa Nessel, Stephen K. Van Den Eeden, Assiamira Ferrara, Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes JAMA. ,vol. 314, pp. 265- 277 ,(2015) , 10.1001/JAMA.2015.7996
L Rushton, S Bagga, R Bevan, T P Brown, J W Cherrie, P Holmes, L Fortunato, R Slack, M Van Tongeren, C Young, S J Hutchings, Occupation and cancer in Britain. British Journal of Cancer. ,vol. 102, pp. 1428- 1437 ,(2010) , 10.1038/SJ.BJC.6605637
Cristina M. Villanueva, Kenneth P. Cantor, Sylvaine Cordier, Jouni J. K. Jaakkola, Will D. King, Charles F. Lynch, Stefano Porru, Manolis Kogevinas, Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology. ,vol. 15, pp. 357- 367 ,(2004) , 10.1097/01.EDE.0000121380.02594.FC
N.Aydin Mungan, Lambertus A.L.M Kiemeney, Jos A.A.M van Dijck, Henk G van der Poel, J.Alfred Witjes, Gender differences in stage distribution of bladder cancer Urology. ,vol. 55, pp. 368- 371 ,(2000) , 10.1016/S0090-4295(99)00481-1